News

T cell therapy called AIC100, which targets the ICAM-1 protein, demonstrated encouraging responses and an acceptable safety profile in patients with two types of advanced thyroid cancer, according to ...
T cell therapy called AIC100, which targets the ICAM-1 protein, demonstrated encouraging responses and an acceptable safety ...
Lirum Therapeutics, Inc. (“Lirum”), an innovative clinical-stage biopharmaceutical company focused on the treatment of ...
From a meeting that celebrates basic research and being "first," a look at 3 data sets on therapies that would break new ...
Two weeks after taking an online "liver cancer cure," a 37-year-old man was brought back to hospital in a near-terminal state.
Teddi Mellencamp attended the Unforgettable Evening 2025 Gala, marking her first appearance at a formal event since sharing her melanoma had metastasized to her brain and lungs earlier this year.